➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Express Scripts
Harvard Business School
AstraZeneca
McKesson

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

BENAZEPRIL HYDROCHLORIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Benazepril Hydrochloride, and when can generic versions of Benazepril Hydrochloride launch?

Benazepril Hydrochloride is a drug marketed by Amneal Pharms, Ani Pharms Inc, Aurobindo Pharma, Casi Pharms Inc, Corepharma, Genpharm, Heritage Pharma, Mylan, Prinston Inc, Sun Pharm Inds Ltd, Teva, Zydus Pharms Usa, Apotex, Mylan Pharms Inc, and Sandoz. and is included in nineteen NDAs.

The generic ingredient in BENAZEPRIL HYDROCHLORIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.

Drug patent expirations by year for BENAZEPRIL HYDROCHLORIDE
Recent Clinical Trials for BENAZEPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Sun Yat-sen UniversityPhase 2/Phase 3
University of NebraskaPhase 4

See all BENAZEPRIL HYDROCHLORIDE clinical trials

Pharmacology for BENAZEPRIL HYDROCHLORIDE

US Patents and Regulatory Information for BENAZEPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 077483-001 Sep 8, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Teva BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076211-002 Feb 11, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Prinston Inc BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076118-001 Feb 11, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076348-001 Feb 11, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076688-001 Feb 11, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Express Scripts
Harvard Business School
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.